201 related articles for article (PubMed ID: 15512889)
1. ALS surrogate markers. MRS.
Kalra S; Arnold DL
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():111-4. PubMed ID: 15512889
[TBL] [Abstract][Full Text] [Related]
2. Effect of creatine supplementation on metabolite levels in ALS motor cortices.
Vielhaber S; Kaufmann J; Kanowski M; Sailer M; Feistner H; Tempelmann C; Elger CE; Heinze HJ; Kunz WS
Exp Neurol; 2001 Dec; 172(2):377-82. PubMed ID: 11716561
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging and magnetic resonance spectroscopy in a patient with amyotrophic lateral sclerosis and frontotemporal dementia.
Sarac H; Zagar M; Vranjes D; Henigsberg N; Bilić E; Pavlisa G
Coll Antropol; 2008 Jan; 32 Suppl 1():205-10. PubMed ID: 18405084
[TBL] [Abstract][Full Text] [Related]
4. Effect of occupational manganese exposure on the central nervous system of welders: 1H magnetic resonance spectroscopy and MRI findings.
Kim EA; Cheong HK; Choi DS; Sakong J; Ryoo JW; Park I; Kang DM
Neurotoxicology; 2007 Mar; 28(2):276-83. PubMed ID: 16824604
[TBL] [Abstract][Full Text] [Related]
5. Study of the features of proton MR spectroscopy ((1)H-MRS) on amyotrophic lateral sclerosis.
Han J; Ma L
J Magn Reson Imaging; 2010 Feb; 31(2):305-8. PubMed ID: 20099342
[TBL] [Abstract][Full Text] [Related]
6. Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study.
Rule RR; Suhy J; Schuff N; Gelinas DF; Miller RG; Weiner MW
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5(3):141-9. PubMed ID: 15512902
[TBL] [Abstract][Full Text] [Related]
7. Role of diffusion tensor imaging or magnetic resonance spectroscopy in the diagnosis and disability assessment of amyotrophic lateral sclerosis.
Liu C; Jiang R; Yi X; Zhu W; Bu B
J Neurol Sci; 2015 Jan; 348(1-2):206-10. PubMed ID: 25524526
[TBL] [Abstract][Full Text] [Related]
8. Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain.
Chan S; Shungu DC; Douglas-Akinwande A; Lange DJ; Rowland LP
Radiology; 1999 Sep; 212(3):763-9. PubMed ID: 10478245
[TBL] [Abstract][Full Text] [Related]
9. Combined structural and neurochemical evaluation of the corticospinal tract in amyotrophic lateral sclerosis.
Pyra T; Hui B; Hanstock C; Concha L; Wong JC; Beaulieu C; Johnston W; Kalra S
Amyotroph Lateral Scler; 2010; 11(1-2):157-65. PubMed ID: 19242831
[TBL] [Abstract][Full Text] [Related]
10. MR spectroscopy evaluation and short-term outcome of olfactory ensheathing cells transplantation in amyotrophic lateral sclerosis patients.
Huang H; Tan K; Chen L; Xue Y; Wang H; Xi H; Liu Y; Zhang F; Zhang J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Jan; 21(1):52-7. PubMed ID: 17305006
[TBL] [Abstract][Full Text] [Related]
11. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS.
Mitsumoto H; Ulug AM; Pullman SL; Gooch CL; Chan S; Tang MX; Mao X; Hays AP; Floyd AG; Battista V; Montes J; Hayes S; Dashnaw S; Kaufmann P; Gordon PH; Hirsch J; Levin B; Rowland LP; Shungu DC
Neurology; 2007 Apr; 68(17):1402-10. PubMed ID: 17452585
[TBL] [Abstract][Full Text] [Related]
12. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
13. [Proton MR spectroscopy studies of the brain in ALS patients].
Bak MI; Domzał-Stryga A; Królicki L; Kwieciński H
Neurol Neurochir Pol; 2001; 35(1 Suppl):61-70. PubMed ID: 11732281
[TBL] [Abstract][Full Text] [Related]
14. Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS.
Rooney WD; Miller RG; Gelinas D; Schuff N; Maudsley AA; Weiner MW
Neurology; 1998 Jun; 50(6):1800-5. PubMed ID: 9633731
[TBL] [Abstract][Full Text] [Related]
15. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis.
Pohl C; Block W; Karitzky J; Träber F; Schmidt S; Grothe C; Lamerichs R; Schild H; Klockgether T
Arch Neurol; 2001 May; 58(5):729-35. PubMed ID: 11346367
[TBL] [Abstract][Full Text] [Related]
16. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.
Appenzeller S; Li LM; Costallat LT; Cendes F
Brain; 2005 Dec; 128(Pt 12):2933-40. PubMed ID: 16195241
[TBL] [Abstract][Full Text] [Related]
17. White matter proton MR spectroscopy in children with isolated developmental delay: does it mean delayed myelination?
Fayed N; Morales H; Modrego PJ; Muñoz-Mingarro J
Acad Radiol; 2006 Feb; 13(2):229-35. PubMed ID: 16428059
[TBL] [Abstract][Full Text] [Related]
18. In-vivo proton MR-spectroscopy of the human brain: assessment of N-acetylaspartate (NAA) reduction as a marker for neurodegeneration.
Block W; Träber F; Flacke S; Jessen F; Pohl C; Schild H
Amino Acids; 2002; 23(1-3):317-23. PubMed ID: 12373553
[TBL] [Abstract][Full Text] [Related]
19. Relationship between cervical cord 1H-magnetic resonance spectroscopy and clinoco-electromyographic profile in amyotrophic lateral sclerosis.
Ikeda K; Murata K; Kawase Y; Kawabe K; Kano O; Yoshii Y; Takazawa T; Hirayama T; Iwasaki Y
Muscle Nerve; 2013 Jan; 47(1):61-7. PubMed ID: 23042532
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]